Question

Difficulty: MediumPreventive Care and Immunizations

An 18-month-old boy is brought to the pediatrician for a well-child visit and vaccination update. He was diagnosed with minimal change disease one month ago and has been taking oral prednisone at a dose of 2 mg/kg/day since the diagnosis. His parents report that he is doing well overall and his edema has resolved. They are concerned about his development, noting that while he can walk backward, scribble with crayons, and use about 15 individual words, he cannot yet jump with both feet or use two-word phrases. The patient missed his 12-month and 15-month appointments and has not received any immunizations since 6 months of age. Vital signs are within normal limits. Physical examination reveals a playful child with a cushingoid appearance but no peripheral edema. Which of the following is the most appropriate management regarding his immunizations and development?

  1. Administer age-appropriate inactivated vaccines, defer live-attenuated vaccines, and reassure the parents regarding his developmentAnswer
  2. B
    Administer all age-appropriate routine vaccines and reassure the parents regarding his development
  3. C
    Administer age-appropriate inactivated vaccines, defer live-attenuated vaccines, and refer for a developmental evaluation
  4. D
    Administer all age-appropriate routine vaccines and refer for a developmental evaluation
  5. E
    Defer all immunizations until the corticosteroid therapy is completed and reassure the parents regarding his development

Answer

Administer age-appropriate inactivated vaccines, defer live-attenuated vaccines, and reassure the parents regarding his development
The correct management is to administer inactivated vaccines, defer live-attenuated vaccines, and reassure the parents. This patient is receiving high-dose systemic corticosteroids (defined as ≥2 mg/kg/day or ≥20 mg/day of prednisone or its equivalent for 14 or more consecutive days). This level of therapy induces profound immunosuppression. Consequently, live-attenuated vaccines (such as MMR and Varicella, which he missed at 12 and 15 months) are strictly contraindicated due to the risk of uncontrolled vaccine-strain infection, and must be deferred until at least one month after steroid discontinuation. However, inactivated vaccines (such as DTaP, IPV, Hib, PCV15, and HepA) are entirely safe for immunocompromised patients and should be administered immediately to provide critical protection. Developmentally, the child is perfectly on track for an 18-month-old: he can walk backwards, scribble, and has a typical vocabulary of about 15 words. His parents' concerns involve milestones expected at 24 months (jumping with both feet, two-word phrases), so reassurance is the only developmental intervention required.

Step-by-Step Solution

1
Evaluate the patient's medication list for contraindications to immunizations.
The patient is on high-dose systemic corticosteroids (2 mg/kg/day for 4 weeks), which causes significant immunosuppression.
Immunosuppression dictates which vaccines can be safely administered.
2
Determine the appropriate vaccine administration plan based on immune status.
Live-attenuated vaccines (e.g., MMR, varicella) must be deferred, while inactivated vaccines (e.g., DTaP, Hib, PCV, HepA) are safe and should be given to catch the patient up.
Live vaccines carry a risk of vaccine-strain disseminated infection in immunocompromised hosts, but inactivated vaccines carry no such risk.
3
Assess the patient's developmental milestones against standardized age expectations.
Walking backward, scribbling, and a 15-word vocabulary are normal for 18 months. Jumping and two-word phrases are 24-month milestones.
Accurate milestone tracking prevents unnecessary referrals and provides appropriate parental reassurance.

Key Concept

Live vaccines are contraindicated in patients on high-dose corticosteroids, but inactivated vaccines should be given; 18-month milestones include walking backwards, 10-25 words, and scribbling.
Rate this question